Texas Drug Penalty Groups haldol pregnancy PG1, PG1a, PG2, PG3, PG4

(1) any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, if the existence of these salts, isomers, and salts of isomers is possible within the specific chemical haldol pregnancy designation:

• dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule haldol pregnancy in a U.S. Food and drug administration approved drug product (some trade or other names for dronabinol: (a6ar-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- (trans)- tetrahydrocannabinol);

• tetrahydrocannabinols, other than marihuana, and synthetic equivalents of the substances contained in the plant, or in the resinous extractives of cannabis, or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity haldol pregnancy such as:

(3) unless specifically excepted or unless listed in another penalty group, a material, compound, mixture, or preparation that contains any quantity of the following substances haldol pregnancy having a potential for abuse associated with a depressant or haldol pregnancy stimulant effect on the central nervous system:

• methcathinone (some trade or other names: 2- methylamino-propiophenone; alpha-(methylamino)propriophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N- methylaminopropriophenone; monomethylpropion; ephedrone, N- methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR 1431);

(6) 2,5-dimethoxyphenethylamine and any compound structurally derived from 2,5-dimethoxyphenethylamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as:

(7) 2,5-dimethoxyamphetamine and any compound structurally derived from 2,5-dimethoxyamphetamine by substitution at the 4-position of the phenyl ring to any extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents), including, by example, compounds such as:

(c) to the extent subsection (a)(4), (5), (6), or (7) conflicts with another provision or this subtitle or another law, the other provision or the other law prevails. If a substance listed in this section is also listed haldol pregnancy in another penalty group, the listing in the other penalty group controls.

(2) “group A component” is one of the following: adamantane, benzene, cycloalkylmethyl, isoquinoline, methylpiperazine, naphthalene, phenyl, quinoline, tetrahydronaphthalene, tetramethylcyclopropane, amino oxobutane, amino dimethyl oxobutane, amino phenyl oxopropane, methyl methoxy oxobutane, methoxy dimethyl oxobutane, methoxy phenyl oxopropane, or an amino acid.

(b) penalty group 2-A consists of any material, compound, mixture, or preparation that contains any quantity of a natural or haldol pregnancy synthetic chemical substance, including its salts, isomers, and salts of isomers, listed by name in this subsection or contained within one haldol pregnancy of the structural classes defined in this subsection:

(2) cyclohexylphenol: any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not substituted in the cyclohexyl ring to any haldol pregnancy extent, including:

(4) tetramethylcyclopropyl thiazole: any compound structurally derived from 2,2,3,3-tetramethyl-N-(thiazol- 2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen atom of the thiazole haldol pregnancy ring, whether or not further substituted in the thiazole ring to haldol pregnancy any extent, whether or not substituted in the tetramethylcyclopropyl ring to any haldol pregnancy extent, including:

(5) any compound containing a core component substituted at the 1-position to any extent, and substituted at the 3-position with a link component attached to a group A haldol pregnancy component, whether or not the core component or group A component haldol pregnancy are further substituted to any extent, including:

(6) any compound containing a core component substituted at the 1-position to any extent, and substituted at the 2-position with a link component attached to a group A haldol pregnancy component, whether or not the core component or group A component haldol pregnancy are further substituted to any extent, including:

(7) any compound containing a core component substituted at the 3-position to any extent, and substituted at the 2-position with a link component attached to a group A haldol pregnancy component, whether or not the core component or group A component haldol pregnancy are further substituted to any extent, including:

(8) any compound containing a core component substituted at the 9-position to any extent, and substituted at the 3-position with a link component attached to a group A haldol pregnancy component, whether or not the core component or group A component haldol pregnancy are further substituted to any extent, including:

• tiletamine and zolazepam in combination, and its salts. (some trade or other names for a tiletamine-zolazepam combination product: telazol, for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2-fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4-e](1,4)-d diazepin-7(1H)-one, flupyrazapon);

(6) peyote, unless unharvested and growing in its natural state, meaning all parts of the plant classified botanically as lophophora, whether growing or not, the seeds of the plant, an extract from a part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or extracts;

(7) unless listed in another penalty group, a material, compound, mixture, or preparation that contains any quantity of the following substances haldol pregnancy having a stimulant effect on the central nervous system, including the substance’s salts, optical, position, or geometric isomers, and salts of the substance’s isomers, if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical haldol pregnancy designation:

(8) unless specifically excepted or unless listed in another penalty group, a material, compound, mixture, or preparation that contains any quantity of the following substance, including its salts: dextropropoxyphene (alpha-(+)- 4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane);

(9) an anabolic steroid, including any drug or hormonal substance, or any substance that is chemically or pharmacologically related to haldol pregnancy testosterone, other than an estrogen, progestin, dehydroepiandrosterone, or corticosteroid, and promotes muscle growth, including the following drugs and substances and any salt, ester, or ether of the following drugs and substances:

(10) salvia divinorum, unless unharvested and growing in its natur al state, meaning all parts of that plant, whether growing or not, the seeds of that plant, an extract from a part of that plant, and every compound, manufacture, salt, derivative, mixture, or preparation of that plant, its seeds, or extracts, including salvinorin A.

(1) if the compound, mixture, or preparation contains one or more active medicinal ingredients not haldol pregnancy having a stimulant effect on the central nervous system and haldol pregnancy if the admixtures are included in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the haldol pregnancy substances that have a stimulant effect on the central nervous haldol pregnancy system.

(c) penalty group 3 does not include a compound, mixture, or preparation containing a depressant substance listed in subsection (a)(2) or (a)(5) if the compound, mixture, or preparation contains one or more active medicinal ingredients not haldol pregnancy having a depressant effect on the central nervous system and haldol pregnancy if the admixtures are included in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the haldol pregnancy substances that have a depressant effect on the central nervous haldol pregnancy system.

RELATED_POSTS